catalog number : 
MBS241133
products full name : 
Rabbit Polyclonal (IgG) to Human AKT1 / AKT
products short name : 
AKT1 / AKT
products name syn : 
Anti-AKT1 / AKT Antibody (Thr308) IHC-plus; AKT1; AKT; AKT-1; C-AKT; Pan-AKT; PKB alpha; PKBalpha; Proto-oncogene c-Akt; Protein kinase B; Rac protein kinase alpha; PRKBA; Protein kinase B alpha; RAC-PK-alpha; PKB; PKB-ALPHA; RAC; RAC-ALPHA; Human AKT1; AKT
other names : 
RAC-alpha serine/threonine-protein kinase; RAC-alpha serine/threonine-protein kinase; RAC-alpha serine/threonine-protein kinase; AKT1m; PKB alpha; RAC-PK-alpha; proto-oncogene c-Akt; protein kinase B alpha; rac protein kinase alpha; v-akt murine thymoma viral oncogene homolog 1; Protein kinase B; PKB; Protein kinase B alpha; PKB alpha; Proto-oncogene c-Akt; RAC-PK-alpha
products gene name : 
AKT1
products gene name syn : 
AKT
other gene names : 
AKT1; AKT1; AKT; PKB; RAC; CWS6; PRKBA; PKB-ALPHA; RAC-ALPHA; PKB; RAC; PKB; PKB alpha
uniprot entry name : 
AKT1_HUMAN
reactivity : 
Human, Mouse, Rat
specificity : 
Amino acids surrounding threonine 308 of human AKT
purity : 
Immunoaffinity Purified
form : 
PBS, 0.02% sodium azide, 50% glycerol.
storage stability : 
Long term: -70 degree C; Short term: -20 degree C
tested application : 
Immunohistochemistry (IHC - Paraffin), Western Blot (WB)
app notes : 
IHC-P (20 ug/ml), WB. Usage: Immunohistochemistry: was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary anti.
other info1 : 
Target Species: Human.  Immunogen Description: Synthetic peptide from human AKT1.
other info2 : 
Immunogen Type: Synthetic peptide.  Immunogen: AKT1 / AKT antibody was raised against synthetic peptide from human AKT1.  Antigen Modification: Thr308
products categories : 
Family: Protein Kinase. Subfamily: RAC/AKT
products description : 
AKT1 encodes a RAC/AKT -type protein kinase that contains a N-terminal pleckstrin-homology (PH) domain and a central catalytic domain closely related to both cAMP-dependent protein kinase and protein kinase C. The protein is a member of PI3K-mediated signaling pathways associated with the regulation of proliferation, survival, protein synthesis, and metabolism.
ncbi acc num : 
NP_005154.2
ncbi gb acc num : 
NM_005163.2
ncbi mol weight : 
48,347 Da
ncbi pathways : 
AGE/RAGE Pathway  698754!!AKT Phosphorylates Targets In The Cytosol Pathway  106475!!AKT Phosphorylates Targets In The Nucleus Pathway  106476!!AKT-mediated Inactivation Of FOXO1A Pathway  106333!!AMPK Signaling Pathway  198868!!AMPK Signaling Pathway  989139!!AMPK Signaling Pathway  992181!!Activation Of BAD And Translocation To Mitochondria Pathway  105659!!Activation Of BH3-only Proteins Pathway  105658!!Acute Myeloid Leukemia Pathway  83117
ncbi summary : 
The serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery. Mutations in this gene have been associated with the Proteus syndrome. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2011]